vTv Therapeutics

VTVT · NASDAQ

$27.85+$0.905 (+3.36%)TodayMarket closed ·
Prev close $26.94

Who owns VTVT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 73.6% of VTVT’s shares.

  • MacAndrews & Forbes Holdings, Inc.37.8%
  • Samsara BioCapital, LLC7.6%
  • Millennium Management LLC6.8%
  • Fidelity Management & Research Company LLC6.6%
  • Next 6 largest institutions14.7%
  • All other shareholders26.4%
Top institutional holders of VTVT
HolderShares% of shares
MacAndrews & Forbes Holdings, Inc.1.49M37.82%
Samsara BioCapital, LLC298.50K7.58%
Millennium Management LLC269.87K6.85%
Fidelity Management & Research Company LLC260.39K6.61%
Invus Public Equities Advisors, LLC163.00K4.14%
Baker Bros. Advisors LP148.31K3.76%
Vanguard Capital Management, LLC94.46K2.40%
Trails Edge Capital Partners LP85.19K2.16%
Aisling Capital Management LP50.00K1.27%
Marshall Wace LLP39.56K1.00%

Largest mutual fund holders

Top mutual fund holders of VTVT
HolderShares% of shares
Fidelity Select Biotechnology Portfolio260.39K6.61%
Vanguard Total Stock Market Index Fund60.76K1.54%
Vanguard Extended Market Index Fund31.40K0.80%
Fidelity Extended Market Index Fund14.02K0.36%
iShares Micro-Cap ETF7.33K0.19%

Short interest

Settled Sep 30, 2026

Shares short
156.75K
Days to cover
3.30
% of shares outstanding
3.98%
Average daily volume
47.56K
Change since last report
−2.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.